ALKS 内幕交易
ALKS 的 SEC Form 4 内幕交易记录
总交易
154
买入
0
买入总额
-
卖出总额
$12.9M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(38) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 16,217 | $42.36 | $687K | 2026-05-29 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(30) | SNYDERMAN NANCY LYNN MD | - | 卖出 | 44,472 | $50.35 | $2.2M | 2026-08-03 | 董事卖出, 百万级卖出 |
| ★★★★★(28) | COOKE SHANE | - | 卖出 | 32,113 | $34.78 | $1.1M | 2026-02-02 | 董事卖出, 百万级卖出 |
| ★★★★★(20) | COOKE SHANE | - | 卖出 | 61,200 | $34.57 | $2.1M | 2026-02-02 | 董事卖出, 百万级卖出 |
| ★★★★★(16) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 6,890 | $29.29 | $202K | 2026-03-02 | 高管卖出, 减持超20%持仓 |
| ★★★★★(15) | COOKE SHANE | - | 卖出 | 29,087 | $34.34 | $999K | 2026-02-02 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(10) | WRIGHT CHRISTOPHER I | - | 卖出 | 2,000 | $45.10 | $90K | 2026-06-12 | 董事卖出 |
| ★★★★★(8) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $41.03 | $83K | 2026-10-02 | 高管卖出 |
| ★★★★★(8) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $48.01 | $98K | 2026-09-03 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $46.99 | $423K | 2026-09-01 | 高管卖出 |
| ★★★★★(8) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 7,576 | $49.23 | $373K | 2026-08-17 | 高管卖出 |
| ★★★★★(8) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 664 | $49.65 | $33K | 2026-08-17 | 高管卖出 |
| ★★★★★(8) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 6,912 | $49.19 | $340K | 2026-08-17 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $48.58 | $437K | 2026-08-03 | 高管卖出 |
| ★★★★★(8) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $48.58 | $99K | 2026-08-03 | 高管卖出 |
| ★★★★★(8) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $54.03 | $110K | 2026-07-06 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 700 | $52.13 | $36K | 2026-07-01 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 8,300 | $51.46 | $427K | 2026-07-01 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $51.51 | $464K | 2026-07-01 | 高管卖出 |
| ★★★★★(8) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $43.05 | $88K | 2026-06-04 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $41.67 | $375K | 2026-06-01 | 高管卖出 |
| ★★★★★(8) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $33.20 | $68K | 2026-05-04 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $33.40 | $301K | 2026-05-01 | 高管卖出 |
| ★★★★★(8) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $34.57 | $70K | 2026-04-06 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $35.51 | $320K | 2026-04-01 | 高管卖出 |
| ★★★★★(8) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $29.76 | $61K | 2026-03-03 | 高管卖出 |
| ★★★★★(8) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $29.29 | $60K | 2026-03-02 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $29.72 | $267K | 2026-03-02 | 高管卖出 |
| ★★★★★(8) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 6,000 | $30.00 | $180K | 2026-03-02 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 4,000 | $33.54 | $134K | 2026-02-02 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $33.93 | $305K | 2026-02-02 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | $34.24 | $171K | 2026-02-02 | 高管卖出 |
| ★★★★★(8) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | $30.00 | $150K | 2026-01-08 | 高管卖出 |
| ★★★★★(0) | REED JOSHUA | SVP, Chief Financial Officer | 卖出 | 9,164 | $41.22 | $378K | 2026-10-08 | |
| ★★★★★(0) | REED JOSHUA | SVP, Chief Financial Officer | 卖出 | 4,069 | $40.11 | $163K | 2026-10-08 | |
| ★★★★★(0) | WHITAKER ANNE CLEM | - | 卖出 | 7,239 | - | - | 2026-10-07 | |
| ★★★★★(0) | WHITAKER ANNE CLEM | - | 卖出 | 17,998 | - | - | 2026-10-07 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | - | - | 2026-09-01 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | President & CEO, Alkermes plc | 卖出 | 93,229 | - | - | 2026-08-05 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | President & CEO, Alkermes plc | 卖出 | 124,305 | - | - | 2026-08-05 | |
| ★★★★★(0) | SNYDERMAN NANCY LYNN MD | - | 卖出 | 27,948 | $46.72 | $1.3M | 2026-08-03 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 4,896 | - | - | 2026-08-03 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 104 | $19.34 | $2K | 2026-08-03 | |
| ★★★★★(0) | SNYDERMAN NANCY LYNN MD | - | 卖出 | 16,524 | $46.72 | $772K | 2026-08-03 | |
| ★★★★★(0) | SNYDERMAN NANCY LYNN MD | - | 卖出 | 0 | - | - | 2026-08-03 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | $19.34 | $97K | 2026-07-01 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | $19.34 | $97K | 2026-06-01 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 3,392 | - | - | 2026-05-29 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 12,825 | $19.34 | $248K | 2026-05-29 | |
| ★★★★★(0) | MCKEON BRIAN P | - | 卖出 | 6,142 | - | - | 2026-05-21 | |
| ★★★★★(0) | COOKE SHANE | - | 卖出 | 3,207 | $36.95 | $118K | 2026-05-21 | |
| ★★★★★(0) | GAYNOR RICHARD | - | 卖出 | 1,475 | $36.95 | $55K | 2026-05-21 | |
| ★★★★★(0) | LAURENCIN CATO T | - | 卖出 | 1,475 | $36.95 | $55K | 2026-05-21 | |
| ★★★★★(0) | COOKE SHANE | - | 卖出 | 6,142 | - | - | 2026-05-21 | |
| ★★★★★(0) | SNYDERMAN NANCY LYNN MD | - | 卖出 | 1,475 | $36.95 | $55K | 2026-05-21 | |
| ★★★★★(0) | SNYDERMAN NANCY LYNN MD | - | 卖出 | 6,142 | - | - | 2026-05-21 | |
| ★★★★★(0) | LAURENCIN CATO T | - | 卖出 | 6,142 | - | - | 2026-05-21 | |
| ★★★★★(0) | WILSON FRANK ANDERS | - | 卖出 | 6,142 | - | - | 2026-05-21 | |
| ★★★★★(0) | LURKER NANCY | - | 卖出 | 1,475 | $36.95 | $55K | 2026-05-21 | |
| ★★★★★(0) | LURKER NANCY | - | 卖出 | 6,142 | - | - | 2026-05-21 | |
| ★★★★★(0) | GAYNOR RICHARD | - | 卖出 | 6,142 | - | - | 2026-05-21 | |
| ★★★★★(0) | WRIGHT CHRISTOPHER I | - | 卖出 | 6,142 | - | - | 2026-05-21 | |
| ★★★★★(0) | MCKEON BRIAN P | - | 卖出 | 1,475 | $36.95 | $55K | 2026-05-21 | |
| ★★★★★(0) | WRIGHT CHRISTOPHER I | - | 卖出 | 1,475 | $36.95 | $55K | 2026-05-21 | |
| ★★★★★(0) | WILSON FRANK ANDERS | - | 卖出 | 1,475 | $36.95 | $55K | 2026-05-21 | |
| ★★★★★(0) | LURKER NANCY | - | 卖出 | 11,538 | - | - | 2026-05-20 | |
| ★★★★★(0) | SNYDERMAN NANCY LYNN MD | - | 卖出 | 5,409 | - | - | 2026-05-20 | |
| ★★★★★(0) | GAYNOR RICHARD | - | 卖出 | 5,409 | - | - | 2026-05-20 | |
| ★★★★★(0) | SNYDERMAN NANCY LYNN MD | - | 卖出 | 0 | - | - | 2026-05-20 | |
| ★★★★★(0) | MCKEON BRIAN P | - | 卖出 | 0 | - | - | 2026-05-20 | |
| ★★★★★(0) | COOKE SHANE | - | 卖出 | 11,538 | - | - | 2026-05-20 | |
| ★★★★★(0) | LAURENCIN CATO T | - | 卖出 | 5,409 | - | - | 2026-05-20 | |
| ★★★★★(0) | WRIGHT CHRISTOPHER I | - | 卖出 | 5,409 | - | - | 2026-05-20 | |
| ★★★★★(0) | WILSON FRANK ANDERS | - | 卖出 | 11,538 | - | - | 2026-05-20 | |
| ★★★★★(0) | LURKER NANCY | - | 卖出 | 5,409 | - | - | 2026-05-20 | |
| ★★★★★(0) | WILSON FRANK ANDERS | - | 卖出 | 5,409 | - | - | 2026-05-20 | |
| ★★★★★(0) | MCKEON BRIAN P | - | 卖出 | 11,538 | - | - | 2026-05-20 | |
| ★★★★★(0) | LAURENCIN CATO T | - | 卖出 | 11,538 | - | - | 2026-05-20 | |
| ★★★★★(0) | MCKEON BRIAN P | - | 卖出 | 5,409 | - | - | 2026-05-20 | |
| ★★★★★(0) | WRIGHT CHRISTOPHER I | - | 卖出 | 11,538 | - | - | 2026-05-20 | |
| ★★★★★(0) | SNYDERMAN NANCY LYNN MD | - | 卖出 | 11,538 | - | - | 2026-05-20 | |
| ★★★★★(0) | GAYNOR RICHARD | - | 卖出 | 11,538 | - | - | 2026-05-20 | |
| ★★★★★(0) | COOKE SHANE | - | 卖出 | 5,409 | - | - | 2026-05-20 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | $19.34 | $97K | 2026-05-01 | |
| ★★★★★(0) | LURKER NANCY | - | 卖出 | 3,751 | - | - | 2026-04-11 | |
| ★★★★★(0) | LURKER NANCY | - | 卖出 | 901 | $33.36 | $30K | 2026-04-11 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | $19.34 | $97K | 2026-04-01 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 78,292 | - | - | 2026-03-02 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 94,900 | - | - | 2026-03-02 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 38,568 | - | - | 2026-03-02 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 83,037 | - | - | 2026-03-02 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 44,078 | - | - | 2026-03-02 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 30,854 | - | - | 2026-03-02 | |
| ★★★★★(0) | REED JOSHUA | SVP, Chief Financial Officer | 卖出 | 66,430 | - | - | 2026-03-02 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 66,430 | - | - | 2026-03-02 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | - | - | 2026-03-02 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 14,176 | - | - | 2026-03-02 | |
| ★★★★★(0) | REED JOSHUA | SVP, Chief Financial Officer | 卖出 | 30,854 | - | - | 2026-03-02 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 15,033 | - | - | 2026-03-02 | |
| ★★★★★(0) | POPS RICHARD F | Director and CEO, Alkermes plc | 卖出 | 88,843 | - | - | 2026-03-02 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 36,364 | - | - | 2026-03-02 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 808 | $30.73 | $25K | 2026-02-26 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 3,049 | $30.73 | $94K | 2026-02-26 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 3,049 | $30.73 | $94K | 2026-02-26 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 3,695 | $30.73 | $114K | 2026-02-26 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 5,410 | - | - | 2026-02-26 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 6,866 | - | - | 2026-02-26 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 8,322 | - | - | 2026-02-26 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 6,866 | - | - | 2026-02-26 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 2,403 | $30.73 | $74K | 2026-02-26 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 2,747 | - | - | 2026-02-26 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 672 | $32.19 | $22K | 2026-02-23 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 3,414 | $32.19 | $110K | 2026-02-23 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 8,738 | - | - | 2026-02-23 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 3,414 | $32.19 | $110K | 2026-02-23 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 6,407 | - | - | 2026-02-23 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 2,283 | - | - | 2026-02-23 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 3,880 | $32.19 | $125K | 2026-02-23 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 7,689 | - | - | 2026-02-23 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 2,845 | $32.19 | $92K | 2026-02-23 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 7,689 | - | - | 2026-02-23 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 9,300 | - | - | 2026-02-19 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 2,277 | $32.00 | $73K | 2026-02-19 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 7,673 | - | - | 2026-02-19 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 7,673 | - | - | 2026-02-19 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 6,045 | - | - | 2026-02-19 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 3,407 | $32.00 | $109K | 2026-02-19 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 979 | $32.00 | $31K | 2026-02-19 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 4,130 | $32.00 | $132K | 2026-02-19 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 2,991 | - | - | 2026-02-19 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 3,407 | $32.00 | $109K | 2026-02-19 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 3,504 | $32.02 | $112K | 2026-02-18 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 2,126 | $32.02 | $68K | 2026-02-18 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 2,034 | - | - | 2026-02-18 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 1,869 | $32.02 | $60K | 2026-02-18 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 8,897 | - | - | 2026-02-18 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 6,355 | - | - | 2026-02-18 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 8,897 | - | - | 2026-02-18 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 6,355 | - | - | 2026-02-18 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 3,796 | $32.02 | $122K | 2026-02-18 | |
| ★★★★★(0) | PARISI SAMUEL JOSEPH | VP, Finance (Interim PAO) | 卖出 | 706 | $32.02 | $23K | 2026-02-18 | |
| ★★★★★(0) | POPS RICHARD F | Director and CEO, Alkermes plc | 卖出 | 149,580 | - | - | 2026-02-05 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 8,626 | $33.55 | $289K | 2026-02-05 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 6,389 | $33.55 | $214K | 2026-02-05 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 7,619 | $33.55 | $256K | 2026-02-05 | |
| ★★★★★(0) | GAFFIN DAVID JOSEPH | EVP, CLO, Alkermes, Inc. | 卖出 | 25,352 | - | - | 2026-02-05 | |
| ★★★★★(0) | JACKSON BLAIR CURTIS | EVP, Chief Operating Officer | 卖出 | 28,810 | - | - | 2026-02-05 | |
| ★★★★★(0) | NICHOLS CHRISTIAN TODD | SVP, Chief Commercial Officer | 卖出 | 21,127 | - | - | 2026-02-05 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 25,352 | - | - | 2026-02-05 | |
| ★★★★★(0) | POPS RICHARD F | Director and CEO, Alkermes plc | 卖出 | 62,230 | $33.55 | $2.1M | 2026-02-05 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 7,454 | $33.55 | $250K | 2026-02-05 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | - | - | 2026-02-02 | |
| ★★★★★(0) | COOKE SHANE | - | 卖出 | 61,200 | $31.64 | $1.9M | 2026-02-02 | |
| ★★★★★(0) | HOPKINSON CRAIG C. | EVP R&D, Chief Medical Officer | 卖出 | 5,000 | $19.34 | $97K | 2026-01-08 |